GABAB Receptor: The Receptors
Editat de Giancarlo Colomboen Limba Engleză Hardback – 18 sep 2024
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (2) | 912.85 lei 6-8 săpt. | |
| Springer International Publishing – 14 iun 2018 | 912.85 lei 6-8 săpt. | |
| Springer – 19 sep 2025 | 1413.11 lei 38-44 zile | |
| Hardback (2) | 880.34 lei 38-44 zile | |
| Springer International Publishing – 28 dec 2016 | 880.34 lei 38-44 zile | |
| Springer – 18 sep 2024 | 1336.21 lei 6-8 săpt. |
Din seria The Receptors
- 18%
Preț: 917.87 lei - 18%
Preț: 1174.28 lei - 15%
Preț: 632.33 lei - 15%
Preț: 627.14 lei - 18%
Preț: 931.51 lei - 18%
Preț: 913.92 lei - 15%
Preț: 620.86 lei - 18%
Preț: 1495.78 lei - 18%
Preț: 1182.77 lei - 5%
Preț: 1377.33 lei - 18%
Preț: 921.95 lei - 5%
Preț: 1369.44 lei - 18%
Preț: 1183.40 lei - 18%
Preț: 1178.99 lei - 18%
Preț: 1180.51 lei - 18%
Preț: 1171.27 lei - 5%
Preț: 1552.11 lei - 15%
Preț: 670.21 lei - 5%
Preț: 1858.89 lei - 18%
Preț: 918.77 lei -
Preț: 382.10 lei - 18%
Preț: 1180.06 lei - 15%
Preț: 670.07 lei - 18%
Preț: 904.96 lei - 18%
Preț: 922.11 lei - 15%
Preț: 622.29 lei - 24%
Preț: 836.52 lei - 18%
Preț: 913.62 lei - 18%
Preț: 1182.77 lei - 18%
Preț: 923.93 lei - 18%
Preț: 1070.12 lei
Preț: 1336.21 lei
Preț vechi: 1629.52 lei
-18% Nou
Puncte Express: 2004
Preț estimativ în valută:
236.45€ • 277.26$ • 207.65£
236.45€ • 277.26$ • 207.65£
Carte tipărită la comandă
Livrare economică 10-24 februarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031671470
ISBN-10: 3031671473
Pagini: 364
Ilustrații: XXIX, 321 p. 50 illus. in color.
Dimensiuni: 160 x 241 x 26 mm
Greutate: 0.71 kg
Ediția:Second Edition 2024
Editura: Springer
Seria The Receptors
Locul publicării:Cham, Switzerland
ISBN-10: 3031671473
Pagini: 364
Ilustrații: XXIX, 321 p. 50 illus. in color.
Dimensiuni: 160 x 241 x 26 mm
Greutate: 0.71 kg
Ediția:Second Edition 2024
Editura: Springer
Seria The Receptors
Locul publicării:Cham, Switzerland
Cuprins
Section 1: Molecular Biology, Biochemistry, and Functioning of the GABAB Receptor.- GABAB Receptor: Molecular Organization, Function, and Alternative Drug Development by Targeting Protein-Protein Interactions.- GABAB Receptor Functioning: Focus on Allosteric Modulation.- Section 2: Pharmacology of Baclofen.- Historical Overview on Baclofen, the Only GABAB Receptor Agonist Approved and Available for Clinical Use.- Baclofen for the Treatment of Spasticity and Dystonia in Cerebral Palsy.- Baclofen for the Treatment of Cough.- Baclofen for the Treatment of Alcohol Use Disorder.- Baclofen Safety, Toxicity, Withdrawal, and Overdose.- Section 3: Chemistry and Pharmacology of Positive Allosteric Modulators.- Recent Advances on Chemistry of GABAB Receptor Allosteric Modulators.- GABAB Receptor Positive Allosteric Modulators: Novel Approaches for Drug Design and Discovery.- Recent Advances on GABAB Receptor Positive Allosteric Modulators as Potential Pharmacotherapies for Neuropsychiatric Disorders.- Recent Advances on GABAB Receptor Positive Allosteric Modulators as Potential Pharmacotherapies for Substance Use Disorder and Food Addiction.- Recent Advances on GABAB Receptor Positive Allosteric Modulators as Potential Pharmacotherapies for Alcohol Use Disorder.- Section 4: Miscellanea.- γ-Hydroxybutiric Acid: A GABAB/GHB Receptor Agonist with a Unique Neuropharmacological and Therapeutic Profile.- Naturally Occurring GABAB Receptor Ligands.- Norman G. Bowery: A Founding Father of the GABAB Receptor Research Field – Reflections on His Contribution.
Notă biografică
Giancarlo Colombo is a researcher at the Neuroscience Institute, National Research Council of Italy, Cagliari, Italy.
His research interest is primarily on neurobiology and pharmacology of alcohol use disorder, with focus on the role of GABAB receptor in the control of multiple alcohol-related behaviors and development of GABAB receptor ligands as possible pharmacotherapies for alcohol use disorder.
He has published approximately 240 papers in peer-reviewed journals and about 20 book chapters; he was also the editor of the 2016 volume on GABAB receptor.
He serves as co-chief-editor of the journal Alcohol and Alcoholism.
His research interest is primarily on neurobiology and pharmacology of alcohol use disorder, with focus on the role of GABAB receptor in the control of multiple alcohol-related behaviors and development of GABAB receptor ligands as possible pharmacotherapies for alcohol use disorder.
He has published approximately 240 papers in peer-reviewed journals and about 20 book chapters; he was also the editor of the 2016 volume on GABAB receptor.
He serves as co-chief-editor of the journal Alcohol and Alcoholism.
Textul de pe ultima copertă
This new edition presents an up-to-date, comprehensive overview of the GABAB receptor system, including a particular focus on the most recent therapeutic applications and potential. This receptor system has been implicated in several diseases and disorders, including gastroesophageal reflux disease, epilepsy, mood disorders, depression, and alcohol and substance use disorder. The authors, leading researchers in the field, explore a number of approaches, including medicinal chemistry, molecular biology, physiology, and preclinical and clinical pharmacology. The new edition is completely reworked and updated, featuring the latest pharmacological advances on baclofen and positive allosteric modulators.
Caracteristici
Focuses on recent therapeutic applications and future potential for drug discovery Features a bench-to-bedside translational approach Explores specific diseases and disorders in which GABAB receptors have been implicated